The Role of NIH in Drug Development Innovation and Its Impact on Patient Access: Proceedings of a Workshop
English
By (author): and Medicine Board on Health Care Services Board on Health Sciences Policy Engineering Health and Medicine Division National Academies of Sciences
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Table of Contents- Front Matter
- Proceedings of a Workshop
- Appendix A: Statement of Task
- Appendix B: Workshop Agenda